v3.26.3
Discontinued Operation - Schedule of Summary Discontinued Cash Flows (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities                
Net loss $ (5,381,441) $ (11,016,480) $ (5,081,982) $ (2,919,346) $ (3,479,833) $ (5,002,891) $ (21,479,903) $ (11,402,070)
Adjustments to reconcile net loss to net cash used in operating activities:                
Inventory write-down             67,050 30,866
Accretion expense             24,680 161,040
Non-cash lease expense             1,228,938 206,415
Changes in operating assets and liabilities:                
Inventories             (197,090) 146,770
Prepaid expenses and other assets             1,100,224 (1,054,592)
Accounts payable and accrued liabilities             424,184 (1,535,900)
Net cash used in operating activities             (14,156,397) (9,271,124)
Cash Flows From Investing Activities                
Proceeds from sales of intellectual properties             1,250,000
Payment for intangible asset – related party             (500,000) (400,000)
Purchase of property and equipment             (137,457) (1,216)
Net cash provided by (used in) investing activities             (4,017,137) (798,042)
Cash Flows From Financing Activities                
Repayments of convertible debt             (61,339) (900,000)
Net cash provided by financing activities             22,168,942 4,981,168
Net increase (decrease) in cash             4,005,025 (5,113,869)
Cash at end of period - continuing operations 4,860,697     1,026,654     4,860,697 1,026,654
Discontinued Operations [Member]                
Cash Flows From Operating Activities                
Net loss             (4,001,819) (5,744,594)
Adjustments to reconcile net loss to net cash used in operating activities:                
Reclassification of cumulative translation adjustment upon liquidation of foreign subsidiary             693,804
Depreciation and amortization             10,119 379,990
Provision for expected credit losses             8,462
Inventory write-down             67,050 30,866
Accretion expense             5,850 103,541
Gain on settlement of debt related to the sale of intellectual property – related party             (348,966)
Gain on settlement of note payable - silent partnership             (111,940) (3,451)
Gain on sale and disposal of assets             (262,083)
Non-cash lease expense             1,214,595 206,415
Changes in operating assets and liabilities:                
Accounts receivable, net             (67,210) 5,988
Accounts receivable - related party             61,030 17,238
Inventories             146,696 (146,770)
Prepaid expenses and other assets             92,982 48,278
Accounts payable and accrued liabilities             (634,379) (750,210)
Accounts payable and accrued expense - related party             (13,956) (982)
Operating lease liabilities             (1,284,993) (260,241)
Net cash used in operating activities             (4,424,758) (6,113,932)
Cash Flows From Investing Activities                
Payment for intangible asset – related party             (350,000) (400,000)
Purchase of property and equipment             (658) (1,216)
Other investing cash flows             3,174
Net cash provided by (used in) investing activities             899,342 (398,042)
Cash Flows From Financing Activities                
Proceeds from intercompany loans             4,227,007 6,510,595
Repayments of convertible debt             (61,339)
Repayments on silent partnerships             (803,940) (55,738)
Net cash provided by financing activities             3,361,728 6,454,857
Effect of changes in exchange rates             9,618 (25,904)
Net increase (decrease) in cash             (154,070) (83,021)
Cash at beginning of period     $ 187,489     $ 178,167 187,489 178,167
Cash at end of period - continuing operations $ 33,419     $ 95,146     $ 33,419 $ 95,146